Q2 2022 Holdings
Filed 2022-08-11 | 214 holdings | $971.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $4.5M | 21,850 | 0.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $6.1M | 73,753 | 0.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $11.6M | 4,717,113 | 1.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.2M | 933,803 | 1.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $15.6M | 503,007 | 1.6% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $20.7M | 941,059 | 2.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $22.2M | 572,621 | 2.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $22.5M | 151,200 | 2.3% |
| Celldex Therapeutics(CLDX) | COM NEW | 15117B202 | $24.9M | 925,000 | 2.6% |
| Atricure Inc(ATRC) | COM | 04963C209 | $26.2M | 641,896 | 2.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $26.8M | 2,671,413 | 2.8% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $28.6M | 3,539,055 | 2.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $31.3M | 817,141 | 3.2% |
| Align Technology Inc(ALGN) | COM | 016255101 | $32.0M | 135,240 | 3.3% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $45.1M | 91,161 | 4.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $46.2M | 545,903 | 4.8% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $49.4M | 231,069 | 5.1% |
| Caredx Inc(CDNA) | COM | 14167L103 | $54.5M | 2,537,524 | 5.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $89.4M | 2,124,276 | 9.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $90.1M | 4,062,792 | 9.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $143.5M | 3,850,171 | 14.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $154.3M | 1,058,186 | 15.9% |